iPLUS patent (Update)
January 24, 2025by iPLUS
As of 21 January 2025, the European Patent Office (EPO) has registered the unitary effect of the iPLUS patent. Here is a copy of the EPO notification (EPO Form 7030) of the registratation.
HomeAuthor
iPLUS
iPLUS patent
December 13, 2024by iPLUS
The iPLUS patent entitled “Nucleic Acid to Activate Protein Expression and Production”, filed by the Institute of Molecular and Cell Biology (IBMC), has priority filing made in Portugal on October 9, 2018, under the number PT115073A, establishing the invention’s protection starting from this date.
During last week we attended #websummit2022 🚀 to promote iPLUS! Thank you to the RESOLVE-Health for allowing us to have this fantastic experience. #iPLUSbiosciences
